JSM 2015 Online Program

Online Program Home
My Program

Legend: Washington State Convention Center = CC, Sheraton Seattle = S, Grand Hyatt = GH and The Conference Center = TCC
* = applied session       ! = JSM meeting theme

Activity Details

260 Mon, 8/10/2015, 2:00 PM - 3:50 PM CC-614
Missing Data II — Contributed Papers
Biopharmaceutical Section , Government Statistics Section
Chair(s): Rajesh Nair, FDA
2:05 PM A Two-Stage, Phase II Clinical Trial Design with Nested Criteria for Early Stopping and Efficacy Daniel Zelterman, Yale University ; Michael Kane, Yale University ; Michelle DeVeaux, Yale University
2:20 PM Similarity Assessment of Chromatographic Fingerprint of Botanical Products Xiaoyu Dong, FDA ; Yi Tsong, FDA ; Zhuang Miao, FDA ; Jinhui Dou, FDA
2:35 PM Improving Power for Biomarker Detection with Joint Modeling of Multiple Endpoints in Early-Phase Clinical Trials Qianying Liu, Sanofi ; Glen Laird, Sanofi ; Wei Zheng, Sanofi
2:50 PM An Empirical Bayesian Approach to Bioequivalence Studies Li He, Merck Research Laboratories ; Robert Capen, Merck Research Laboratories
3:05 PM Automated High-Dimensional Cytometry Analysis to Elucidate Phenotypic and Functional Modulation in Immuno Cellular Subpopulations Shubing Wang, Merck ; An Chi, Merck ; Yujie Qu, Merck
3:20 PM Sample Size Calculation in Clinical Trials with Mixed Binary and Continuous Co-Primary Endpoints Modeled by Gaussian Copulas Beilei Wu, PAREXEL International ; Alexander de Leon, University of Calgary ; Daniel Bonzo, PAREXEL International
3:35 PM Bayesian Prediction Model of Event Times in Randomized Clinical Trial Jiang Li, Novartis ; Wentao Feng, Novartis ; Satrajit Roychoudhury, Novartis Pharmaceuticals

For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home